The role of M3-muscarinic receptor signaling in insulin secretion

Communicative and Integrative Biology

Volumn 4, Issue 4, 2011, Pages 489-491

  Kong, Kok Choi ^a   Tobin, Andrew B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Ankyrin B; Biased ligands; Glucose homeostasis; Insulin secretion; NALCN; Protein kinase D1; RGS4

Indexed keywords

RODENTIA;

EID: 84872542739     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.15716     Document Type: Article

References (14)

1. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 2001; 22:565-604.
2. Malaisse WJ. Stimulus-secretion coupling in the pancreatic B-cell: the cholinergic pathway for insulin release. Diabetes Metab Rev 1986; 2:243-59.
3. 3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 2006; 3:449-61.
4. 3-muscarinic receptor promotes insulin release via receptor phosphorylation/ arrestin-dependent activation of protein kinase D1. Proc Natl Acad Sci USA 2010; 107:21181-6.
5. Sumara G, Formentini I, Collins S, Sumara I, Windak R, Bodenmiller B, et al. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 2009; 136:235-48.
6. Healy JA, Nilsson KR, Hohmeier HE, Berglund J, Davis J, Hoffman J, et al. Cholinergic augmentation of insulin release requires ankyrin-B. Sci Signal 2010; 3:19.
7. 3 muscarinic receptors in a pancreatic beta-cell line. EMBO Rep 2009; 10:873-80.
8. Ruiz de Azua I, Scarselli M, Rosemond E, Gautam D, Jou W, Gavrilova O, et al. RGS4 is a negative regulator of insulin release from pancreatic betacells in vitro and in vivo. Proc Natl Acad Sci USA 2010; 107:7999-8004.
9. Ahren B, Sauerberg P, Thomsen C. Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice. Am J Physiol 1999; 277:93-102.
10. Gautam D, Ruiz de Azua I, Li JH, Guettier JM, Heard T, Cui Y, et al. Beneficial metabolic effects caused by persistent activation of beta-cell M3 muscarinic acetylcholine receptors in transgenic mice. Endocrinology 2010; 151:5185-94.
11. Conn PJ, Christopoulos A, Lindsley CW. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 2009; 8:41-54.
12. May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2007; 47:1-51.
13. Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, et al. A unique mechanism of beta-blocker action: carvedilol stimulates betaarrestin signaling. Proc Natl Acad Sci USA 2007; 104:16657-62.
14. Fielitz J, Kim MS, Shelton JM, Qi X, Hill JA, Richardson JA, et al. Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci USA 2008; 105:3059-63.